ID Biomedical Corp.

2024-08-22

Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Biopharmaceuticals - ID Biomedical Corp.. Develops proteosomes as delivery vehicles, with a gene-based testing platform for the identification of disease-causing bacteria from culture and other growth methods.

Develops proteosomes as delivery vehicles, with a gene-based testing platform for the identification of disease-causing bacteria from culture and other growth methods. Contacts in North America, with head office in Vancouver, British Columbia. (Nasdaq: IDBE)

ID Biomedical Corp.